167 related articles for article (PubMed ID: 35513366)
21. MAFG-AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma.
Xiao M; Liu J; Xiang L; Zhao K; He D; Zeng Q; Zhang Q; Xie D; Deng M; Zhu Y; Zhang Y; Liu Y; Bo H; Liu X; Chen X; Gong L; Bao Y; Hu Y; Cheng Y; Deng L; Zhu R; Xing X; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Cao K
Clin Transl Med; 2020 Dec; 10(8):e241. PubMed ID: 33377647
[TBL] [Abstract][Full Text] [Related]
22. LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression.
Ye C; Qin S; Guo F; Yang Y; Wang H; Zhang C; Yang B
J Cancer; 2022; 13(1):146-152. PubMed ID: 34976178
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.
Bai Y; Ren C; Wang B; Xue J; Li F; Liu J; Yang L
Cancer Gene Ther; 2022 Mar; 29(3-4):277-291. PubMed ID: 34035482
[TBL] [Abstract][Full Text] [Related]
24. Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression.
Weng H; Feng W; Li F; Huang D; Lin L; Wang Z
Growth Factors; 2023 Aug; 41(3):152-164. PubMed ID: 37428861
[TBL] [Abstract][Full Text] [Related]
25. lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1.
Qu Y; Liu J
Onco Targets Ther; 2020; 13():8359-8370. PubMed ID: 32903907
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA MAFG-AS1 facilitates the progression of hepatocellular carcinoma via targeting miR-3196/OTX1 axis.
Hu ZQ; Li HC; Teng F; Chang QM; Wu XB; Feng JF; Zhang ZP
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12131-12143. PubMed ID: 33336731
[TBL] [Abstract][Full Text] [Related]
28. High-expression of LncRNA MAFG-AS1 is associated with the prognostic of patients with colorectal cancer.
Cui W; Wang Y; Shen X; Wu X; Liu H; Xu X
Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1530-1535. PubMed ID: 33295405
[TBL] [Abstract][Full Text] [Related]
29. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.
Sui Y; Lin G; Zheng Y; Huang W
Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MAFG-AS1 Suppresses the Maturation of miR-34a to Promote Glioblastoma Cell Proliferation.
Zhao H; Li J; Yan X; Bian X
Cancer Manag Res; 2021; 13():3493-3501. PubMed ID: 33911899
[TBL] [Abstract][Full Text] [Related]
31. LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis.
Qian CJ; Xu ZR; Chen LY; Wang YC; Yao J
Cancer Manag Res; 2020; 12():6895-6908. PubMed ID: 32801913
[TBL] [Abstract][Full Text] [Related]
32. MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis.
Xiang L; Zeng Q; Liu J; Xiao M; He D; Zhang Q; Xie D; Deng M; Zhu Y; Liu Y; Bo H; Liu X; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Cao K
Sci Bull (Beijing); 2021 Sep; 66(17):1773-1788. PubMed ID: 36654385
[TBL] [Abstract][Full Text] [Related]
33. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
34. LncRNA MAFG-AS1-induced acute myeloid leukemia development via modulating miR-147b/HOXA9.
Yao Q; Zhang L; Liu Z; Yu L; Wang Y; Liu J; Wang Y
Environ Sci Pollut Res Int; 2023 Feb; 30(7):19250-19258. PubMed ID: 36229729
[TBL] [Abstract][Full Text] [Related]
35. MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression.
Li P; Shi Y; Guo M; Xu H; Zhan M; Wang Z; Chen Y
Front Oncol; 2022; 12():856580. PubMed ID: 35992831
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
37. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
38. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
Chen Z; Huang J; Feng Y; Li Z; Jiang Y
J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712
[TBL] [Abstract][Full Text] [Related]
39. LncRNA MAFG-AS1 regulates human periodontal ligament stem cell proliferation and Toll-like receptor 4 expression.
Wangzhou K; Gong L; Liu C; Tan Y; Chen J; Li C; Lai Z; Hao C
Oral Dis; 2020 Sep; 26(6):1302-1307. PubMed ID: 32176822
[TBL] [Abstract][Full Text] [Related]
40. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
